Lee BH, Cho HY, Lee H, Han KH, Kang HG, Ha IS, et al. Genetic

basis of Bartter syndrome in Korea. Nephrol Dial Transplant.

; 27(4):1516-21. [DOI:10.1093/ndt/gfr475] [PMID]

da Silva Cunha T, Heilberg IP. Bartter syndrome: Causes,

diagnosis, and treatment.Int J Nephrol Renovasc Dis. 2018;

:291. [DOI:10.2147/IJNRD.S155397] [PMID] [PMCID]

Vergine G, Fabbri E, Pedini A, Tedeschi S, Borsa N. Bartter

syndrome type 1 presenting as nephrogenic diabetes insipidus.

Case Rep Pediatr. 2018; 2018. [DOI:10.1155/2018/9175271]

[PMID] [PMCID]

Heilberg IP, Tótoli C, Calado JT. Adult presentation of Bartter

syndrome type IV with erythrocytosis. Einstein. 2015;

(4):604-6. [DOI:10.1590/S1679-45082015RC3013] [PMID]

[PMCID]

Nomura N, Kamiya K, Ikeda K, Yui N, Chiga M, Sohara E,

et al. Treatment with 17-allylamino-17-demethoxygeldanamycin

ameliorated symptoms of Bartter syndrome type IV

caused by mutated Bsnd in mice. Biochem Biophys Res Commun.

; 441(3):544-9. [DOI:10.1016/j.bbrc.2013.10.129]

[PMID]

Bartter FC, Pronove P, Gill Jr JR, MacCardle RC. Hyperplasia

of the juxtaglomerular complex with hyperaldosteronism and

hypokalemic alkalosis: A new syndrome. Am J Med. 1962;

(6):811-28. [DOI:10.1016/0002-9343(62)90214-0] [PMID]

Ji W, Foo JN, O’Roak BJ, Zhao H, Larson MG, Simon DB, et

al. Rare independent mutations in renal salt handling genes

contribute to blood pressure variation. Nat Genet. 2008;

(5):592-9. [DOI:10.1038/ng.118] [PMID] [PMCID]

Cruz AJ, Castro A. Gitelman or bartter type 3 syndrome? A

case of distal convoluted tubulopathy caused by CLCNKB

gene mutation. BMJ Case Rep. 2013; 2013:bcr2012007929.

[DOI:10.1136/bcr-2012-007929] [PMID] [PMCID]

Nozu K, Yamamura T, Horinouchi T, Nagano C, Sakakibara

N, Ishikura K, et al. Inherited salt-losing tubulopathy: An old

condition but a new category of tubulopathy. Pediatr Int.

; 62(4):428-37. [DOI:10.1111/ped.14089] [PMID]

Konrad M, Nijenhuis T, Ariceta G, Bertholet-Thomas A,

Calo LA, Capasso G, et al. Diagnosis and management of Bartter

syndrome: Consensus and recommendations from the

ERKNet working group for tubular disorders. ERKNet Working

Group for Tubular Disorders. 2021; 1-17. [Link]

Hennings JC, Andrini O, Picard N, Paulais M, Huebner

AK, Cayuqueo IKL, et al. The ClC-K2 chloride channel is critical

for salt handling in the distal nephron. J Am SocNephrol.

; 28(1):209-17. [DOI:10.1681/ASN.2016010085] [PMID]

[PMCID]

Jentsch TJ, Pusch M. CLC chloride channels and transporters:

Structure, function, physiology, and disease. Physiol-

Rev. 2018; 98(3):1493-590. [DOI:10.1152/physrev.00047.2017]

[PMID]

Konrad M, Nijenhuis T, Ariceta G, Bertholet-Thomas A,

Calo LA, Capasso G, et al. Diagnosis and management of

Bartter syndrome: Executive summary of the consensus and

recommendations from the European rare kidney disease

reference network working group for tubular disorders. Kidney

Int. 2021; 99(2):324-35. [DOI:10.1016/j.kint.2020.10.035]

[PMID]

Lee SE, Han KH, Jung YH, Lee HK, Kang HG, Moon KC,

et al. Renal transplantation in a patient with Bartter syndrome

and glomerulosclerosis. Korean J Pediatr. 2011; 54(1):36.

[DOI:10.3345/kjp.2011.54.1.36] [PMID] [PMCID]